Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Tamargo

Showing results (41-50 of 184) with videos related to

Pageof 19
Sort By:
Pharmacological Research|January 20, 2024
Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effectJuan Tamargo, Julián Villacastín, Ricardo Caballero, et al.
Cardiovascular Research|July 1, 2010
Cardiac electrophysiological effects of nitric oxideJuan Tamargo, Ricardo Caballero, Ricardo Gómez, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|August 24, 2010
Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failureJuan Tamargo, Juan Duarte, Ricardo Caballero, et al.
European Journal of Clinical Pharmacology|April 15, 2015
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainideJuan Tamargo, Jean-Yves Le Heuzey, Phillipe Mabo
Trends in Pharmacological Sciences|March 8, 2005
Angiotensin II, angiotensin II antagonists and spironolactone and their modulation of cardiac repolarizationEva Delpón, Ricardo Caballero, Ricardo Gómez, et al.
Cardiovascular Research|March 17, 2004
Pharmacology of cardiac potassium channelsJuan Tamargo, Ricardo Caballero, Ricardo Gómez, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 9, 2010
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillationEtienne Aliot, Alessandro Capucci, Harry J Crijns, et al.
Circulation Research|September 13, 2003
Thromboxane A2-induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction: role of protein kinase CzetaAngel Cogolludo, Laura Moreno, Lisardo Bosca, et al.
Cardiovascular Research|March 17, 2005
Postnatal maturational shift from PKCzeta and voltage-gated K+ channels to RhoA/Rho kinase in pulmonary vasoconstrictionAngel Cogolludo, Laura Moreno, Federica Lodi, et al.
European Journal of Preventive Cardiology|May 26, 2016
Management of stable angina: A commentary on the European Society of Cardiology guidelinesGiuseppe Ambrosio, Alessandro Mugelli, José Lopez-Sendón, et al.
Pageof 19

Showing results (41-50 of 184) with videos related to

Sort By:
Pageof 19
Pharmacological Research|January 20, 2024
Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effectJuan Tamargo, Julián Villacastín, Ricardo Caballero, et al.
Cardiovascular Research|July 1, 2010
Cardiac electrophysiological effects of nitric oxideJuan Tamargo, Ricardo Caballero, Ricardo Gómez, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|August 24, 2010
Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failureJuan Tamargo, Juan Duarte, Ricardo Caballero, et al.
European Journal of Clinical Pharmacology|April 15, 2015
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainideJuan Tamargo, Jean-Yves Le Heuzey, Phillipe Mabo
Trends in Pharmacological Sciences|March 8, 2005
Angiotensin II, angiotensin II antagonists and spironolactone and their modulation of cardiac repolarizationEva Delpón, Ricardo Caballero, Ricardo Gómez, et al.
Cardiovascular Research|March 17, 2004
Pharmacology of cardiac potassium channelsJuan Tamargo, Ricardo Caballero, Ricardo Gómez, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 9, 2010
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillationEtienne Aliot, Alessandro Capucci, Harry J Crijns, et al.
Circulation Research|September 13, 2003
Thromboxane A2-induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction: role of protein kinase CzetaAngel Cogolludo, Laura Moreno, Lisardo Bosca, et al.
Cardiovascular Research|March 17, 2005
Postnatal maturational shift from PKCzeta and voltage-gated K+ channels to RhoA/Rho kinase in pulmonary vasoconstrictionAngel Cogolludo, Laura Moreno, Federica Lodi, et al.
European Journal of Preventive Cardiology|May 26, 2016
Management of stable angina: A commentary on the European Society of Cardiology guidelinesGiuseppe Ambrosio, Alessandro Mugelli, José Lopez-Sendón, et al.
Pageof 19